Kevin Pollack
2015
In 2015, Kevin Pollack earned a total compensation of $1.3M as CFO at OPIANT PHARMACEUTICALS, a 72% decrease compared to previous year.
Compensation breakdown
| Bonus | $767,500 |
|---|---|
| Salary | $541,598 |
| Total | $1,309,098 |
Pollack received $767.5K in bonus, accounting for 59% of the total pay in 2015.
Pollack also received $541.6K in salary.
Rankings
In 2015, Kevin Pollack's compensation ranked 6,630th out of 13,638 executives tracked by ExecPay. In other words, Pollack earned more than 51.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,630 out of 13,638 | 51st |
Division Mining | 306 out of 612 | 50th |
Major group Metal Mining | 20 out of 96 | 79th |
Source: SEC filing on July 27, 2017.
Pollack's colleagues
We found two more compensation records of executives who worked with Kevin Pollack at OPIANT PHARMACEUTICALS in 2015.